Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
Crossref DOI link: https://doi.org/10.1186/s40425-015-0104-y
Published Online: 2015-12-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castro, Michael P.
Goldstein, Neal
Funding for this research was provided by:
No funding provided
Text and Data Mining valid from 2015-12-01
Article History
Received: 15 September 2015
Accepted: 1 December 2015
First Online: 15 December 2015